Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-17

FDA Approved: LIOTHYRONINE SODIUM — Supplemental Application (Dr. Reddy's Labratories Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Liothyronine Sodium from Dr. Reddy's Laboratories Inc., under ANDA090097, authorizing a change to an already app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liothyronine Sodium (Liothyronine Sodium)

Snippet

SUPPL AP for LIOTHYRONINE SODIUM (LIOTHYRONINE SODIUM)